ABCC2 haplotype is not associated with drug-resistant epilepsy. (Q51891830)

17 April 2018

title

ABCC2 haplotype is not associated with drug-resistant epilepsy. (English)

1 reference

17 April 2018

author name string

Takayuki Seo

1 reference

17 April 2018

Takateru Ishitsu

1 reference

17 April 2018

Kentaro Oniki

1 reference

17 April 2018

Tomohide Abe

1 reference

17 April 2018

Tsuyoshi Shuto

1 reference

17 April 2018

Kazuko Nakagawa

1 reference

17 April 2018

publication date

1 May 2008

1 reference

17 April 2018

Journal of Pharmacy and Pharmacology

published in

1 reference

17 April 2018

volume

1 reference

17 April 2018

issue

1 reference

17 April 2018

page(s)

631-635

1 reference

17 April 2018

Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Likelihood of seizure remission in an adult population with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

MRP2 haplotypes confer differential susceptibility to toxic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Deletion of the distal long arm of chromosome 10; is there a characteristic phenotype? A report of 15 de novo and familial cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

The apical conjugate efflux pump ABCC2 (MRP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Molecular and cellular mechanisms of pharmacoresistance in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Update on pharmacogenetics in epilepsy: a brief review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

MDR1 gene expression in brain of patients with medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.5.0009

21 January 2018

Identifiers

DOI

10.1211/JPP.60.5.0009

1 reference

17 April 2018

1 reference

17 April 2018